Predict | Value-Based Contracts

Differentiate products and establish key partnerships.

Unrelenting increases in healthcare costs and disappointing patient outcomes are accelerating the interest in value-based contracts (VBCs).  By putting data and patients at the center of the transformation, VBCs create a foundation for change, an opportunity for real differentiation, and can unlock new win-win partnership opportunities

AI INFORMS ACTION

identify the right opportunities, foster collaboration, and operationalize contracts.

ClosedLoop generates explainable predictions using thousands of auto-generated, clinically relevant contributing factors.

Determine

Determine which pharmaceuticals work best with value-based pricing agreements and identify opportunities for bundled offerings or digital therapeutics that drive outcomes

Assess

Assess specific opportunities with HCO partners using their data and reach consensus on specific cohorts, key outcomes, and standards for specific metrics

Choose

Choose the right treatments and identify the specific patient cohorts and outcomes that align stakeholders

EXPLORE MORE USE CASES

Urinary Tract Infections

Digital Health

Payers

Providers

Reduce urinary tract infections and improve outcomes.

HEOR & Real World Outcomes

Pharma

Gain precision insights for product and population outcomes.

Metabolic Syndrome

Digital Health

Payers

Providers

Identify metabolic syndrome and promote early detection.

Make AI/ML a core element of your care strategy.

Get in touch today to see the ClosedLoop platform in action.